priority meds semaglutide F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy Semaglutide & tirzepatide are transforming

When to Seek Professional Advice If you have concerns about blood sugar management, weight control, or metabolic health, consulting a healthcare provider is important

Both classes have demonstrated cardio-renal benefits, favorable safety profiles, and reduced polypharmacy

Rosacea can flare throughout an individuals lifetime

Absolute Contraindications Active malignancy Pregnancy and lactation Severe hypoglycemia disorders Known hypersensitivity to IGF-1 Active proliferative retinopathy Relative Contraindications Diabetes mellitus Renal impairment Cardiac impairment History of hyperplasia Family history of certain cancers Severe hepatic impairment Dosing & Administration Starting Dose 2050 mcg/day subcutaneously Begin at the lower end for sensitive patients Assess tolerance for 12 weeks before titration Therapeutic Range 50120 mcg/day for most indications Maximum dose: 200 mcg/day Individualize dosing based on response and tolerance Cycling Protocol 46 weeks on therapy 4 weeks off therapy Helps prevent receptor desensitization Supports long-term efficacy Administration Guidelines Hypoglycemia Prevention: Always administer IGF-1 LR3 with or shortly after carbohydrate-containing meals